FFC Info I got

Discussion in 'Fibromyalgia Main Forum' started by Empower, Jun 20, 2006.

  1. Empower

    Empower New Member

    Fibromyalgia & Fatigue Centers, Inc. Announces Jacob Teitelbaum, MD as New Medical Director
    Dallas, TX, June 19, 2006—Fibromyalgia & Fatigue Centers, Inc. (FFC) has announced the appointment of Jacob Teitelbaum, MD, as their new Medical Director. A leader in effective therapies for Fibromyalgia and Chronic Fatigue Syndrome for the last 25 years, Dr. Teitelbaum will head up medical education programs for the company’s clinics as well as outreach to the public and media. Currently FFC operates 15 clinics in 12 states with plans for expansion into other regions of the U.S.

    Dr. Teitelbaum is author of the perennial best-seller From Fatigued to Fantastic! (Avery Penguin Putnam) and the recently published Pain Free 1-2-3: A Proven Program for Eliminating Chronic Pain Now (McGraw-Hill, 2006). He is senior author of the landmark studies “Effective Treatment of Chronic Fatigue Syndrome and Fibromyalgia—A Placebo-Controlled Study” (Journal of Chronic Fatigue Syndrome, 8:2, 2001), and “Effective Treatment of CFS and Fibromyalgia with D-Ribose.”

    Dr. Kent Holtorf, who served as FFC’s Medical Director since the company’s inception 2 ½ years ago, will assume a new role as Chief of the Medical Advisory Board starting July 1, 2006.

    “We are delighted to have Dr. Teitelbaum as our new Medical Director,” said Robert S. Baurys II, FFC’s Founder and Chairman of the Board. “His expertise in treating Fibromyalgia (FMS) and Chronic Fatigue Syndrome (CFS) for over 25 years reinforces our position as the leading diagnostic and treatment center for these conditions in the world.” He added that Dr. Holtorf and Dr. Teitelbaum are in agreement on foundations for the standard of care for FMS and CFS and are committed to working together to ensure a smooth transition for FFC.

    Dr. Teitelbaum is also Director of the Center for Effective Chronic Fatigue Syndrome/Fibromyalgia Therapies in Annapolis,